Received May 21, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | U833588 | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | UNK | Z010141 | — |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | j757k | PO / MO |
No adverse reaction; Inadvertently administered VAXELIS and VAXNEUNVANCE to a 4- week-old patient.; This non-serious spontaneous Safety Report was received with reference number: 02954933 (Interaction number: 02954926) by partner on 26-FEB-2026 and forwarded on 26-FEB-2026 from a health professional. Due to the nature of the event the causal relationship between the event of Inadvertently administered VAXELIS and VAXNEUNVANCE to a 4- week-old patient" and Vaxelis is not applicable. This case is considered off label. Further information is expected. NON-SIGNIFICANT FOLLOW-UP INFORMATION was received by partner on 12-MAR-2026 and forwarded on 13-MAR-2026 from a health professional. Due to the nature of the event the causal relationship between the event of Inadvertently administered VAXELIS and VAXNEUNVANCE to a 4- week-old patient" and Vaxelis is not applicable. No further information is expected. NON-SIGNIFICANT FOLLOW-UP INFORMATION was received through fax on 30-MAR-2026 from a health professional. Due to the nature of the event the causal relationship between the event of Inadvertently administered VAXELIS and VAXNEUNVANCE to a 4- week-old patient" and Vaxelis is not applicable. No further information is expected.
Prophylaxis